Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Post by jopatcloon Mar 29, 2024 10:40am
58 Views
Post# 35960053

Posted Bart 🚀 Elevating MedTech Ambitions with The Dawning

Posted Bart 🚀 Elevating MedTech Ambitions with The Dawning
Elevating MedTech Ambitions with The Dawning

Embarking on the MedTech market is akin to traversing through Jim Collins' conceptual landscape in "From Good To Great." It's an intricate journey where The Dawning serves as your seasoned guide, someone who not only knows the scientific foundations but masters the market's diverse languages and customs, ensuring not just progress but success.

At The Dawning, we understand that while founders may specialize in science and technology, and investors in ROI and portfolio management, they may need more time to fully grasp the market and operational dynamics. It is here, in this route-to-market jungle, that our team spirit reflects the very essence of Collins' wisdom—the need for discipline, unity, and seasoned guidance to not just survive, but thrive.

Discover how The Dawning can guide your MedTech innovation to market success at www.thedawning.world. For insights into transforming from good to great, delve into Jim Collins' work at www.jimcollins.com.

Let me know your thoughts and experiences, and share (repost) to educate others!

TheDawning MedTechInnovation GoodToGreat MarketSuccess UnifiedTeam BartHendriks JimCollins

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities